Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome

References

1. 1.↵
   1. Jiricny J

   . The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006;7:335–46 doi:10.1038/nrm1907 pmid:16612326

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Wimmer K,
   2. Kratz CP

   . Constitutional mismatch repair-deficiency syndrome. Haematologica 2010;95:699–701 doi:10.3324/haematol.2009.021626 pmid:20442441

   FREE Full Text
3. 3.↵
   1. Wimmer K,
   2. Rosenbaum T,
   3. Messiaen L

   . Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1. Clin Genet 2017;91:507–19 doi:10.1111/cge.12904 pmid:27779754

   CrossRefPubMed
4. 4.↵
   1. Durno C,
   2. Boland CR,
   3. Cohen S, et al

   . Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2017;152:1605–14 doi:10.1053/j.gastro.2017.02.011 pmid:28363489

   CrossRefPubMed
5. 5.↵
   1. Wimmer K,
   2. Kratz CP,
   3. Vasen HF, et al

   ; EU-Consortium Care for CMMRD (C4CMMRD). Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European Consortium “Care for CMMRD” (C4CMMRD). J Med Genet 2014;51:355–65 doi:10.1136/jmedgenet-2014-102284 pmid:24737826

   Abstract/FREE Full Text
6. 6.↵
   1. Vasen HF,
   2. Ghorbanoghi Z,
   3. Bourdeaut F, et al

   ; EU-Consortium Care for CMMR-D (C4CMMR-D). Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet 2014;51:283–93 doi:10.1136/jmedgenet-2013-102238 pmid:24556086

   Abstract/FREE Full Text
7. 7.↵
   1. Johannesma PC,
   2. van der Klift HM,
   3. van Grieken NC, et al

   . Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations. Clin Genet 2011;80:243–55 doi:10.1111/j.1399-0004.2011.01635.x pmid:21261604

   CrossRefPubMed
8. 8.↵
   1. Tabori U,
   2. Hansford JR,
   3. Achatz MI, et al

   . Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 2017;23:e32–37 doi:10.1158/1078-0432.CCR-17-0574 pmid:28572265

   Abstract/FREE Full Text
9. 9.↵
   1. Aronson M,
   2. Gallinger S,
   3. Cohen Z, et al

   . Gastrointestinal findings in the largest series of patients with hereditary biallelic mismatch repair deficiency syndrome: report from the international consortium. Am J Gastroenterol 2016;111:275–84 doi:10.1038/ajg.2015.392 pmid:26729549

   CrossRefPubMed
10. 10.↵
    1. Kim B,
    2. Tabori U,
    3. Hawkins C

    . An update on the CNS manifestations of brain tumor polyposis syndromes. Acta Neuropathol 2020 Jan 22. [Epub ahead of print] doi:10.1007/s00401-020-02124-y pmid:31970492

    CrossRefPubMed
11. 11.↵
    1. Bouffet E,
    2. Larouche V,
    3. Campbell BB, et al

    . Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J Clin Oncol 2016;34:2206–01 doi:10.1200/JCO.2016.66.6552 pmid:27001570

    Abstract/FREE Full Text
12. 12.↵
    1. Q Rana H,
    2. Syngal S

    . Biallelic mismatch repair deficiency: management and prevention of a devastating manifestation of the Lynch syndrome. Gastroenterology 2017;152:1254–57 doi:10.1053/j.gastro.2017.03.013 pmid:28327367

    CrossRefPubMed
13. 13.↵
    1. Shinagare AB,
    2. Giardino AA,
    3. Jagannathan JP, et al

    . Hereditary cancer syndromes: a radiologist’s perspective. AJR Am J Roentgenol 2011;197:W1001–07 doi:10.2214/AJR.11.6465 pmid:22109313

    CrossRefPubMed
14. 14.↵
    1. Bakry D,
    2. Aronson M,
    3. Durno C, et al

    . Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the Constitutional Mismatch Repair Deficiency Consortium. Eur J Cancer 2014;50:987–96 doi:10.1016/j.ejca.2013.12.005 pmid:24440087

    CrossRefPubMed
15. 15.↵
    1. Broniscer A,
    2. Baker SJ,
    3. West AN, et al

    . Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 2007;25:682–89 doi:10.1200/JCO.2006.06.8213 pmid:17308273

    Abstract/FREE Full Text
16. 16.↵
    1. Paugh BS,
    2. Qu C,
    3. Jones C, et al

    . Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 2010;28:3061–68 doi:10.1200/JCO.2009.26.7252 pmid:20479398

    Abstract/FREE Full Text
17. 17.↵
    1. Michaeli O,
    2. Tabori U

    . Pediatric high-grade gliomas in the context of cancer predisposition syndromes. J Korean Neurosurg Soc 2018;61:319–332.doi:10.3340/jkns.2018.0031 pmid:29742882

    CrossRefPubMed
18. 18.↵
    1. Shlien A,
    2. Campbell BB,
    3. de Borja R, et al

    ; Biallelic Mismatch Repair Deficiency Consortium. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet 2015;47:257–62 doi:10.1038/ng.3202 pmid:25642631

    CrossRefPubMed
19. 19.↵
    1. Itoh T,
    2. Magnaldi S,
    3. White RM, et al

    . Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 1994;15:1513–19 pmid:7985572

    Abstract/FREE Full Text
20. 20.↵
    1. Baas AF,
    2. Gabbett M,
    3. Rimac M, et al

    . Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome. Eur J Hum Genet 2013;21:55–61 doi:10.1038/ejhg.2012.117 pmid:22692065

    CrossRefPubMed
21. 21.↵
    1. Shiran SI,
    2. Ben-Sira L,
    3. Elhasid R, et al

    . Multiple brain developmental venous anomalies as a marker for constitutional mismatch repair deficiency syndrome. AJNR Am J Neuroradiol 2018;39:1943–46 doi:10.3174/ajnr.A5766 pmid:30166433

    Abstract/FREE Full Text
22. 22.↵
    1. Gökçe E,
    2. Acu B,
    3. Beyhan M, et al

    . Magnetic resonance imaging findings of developmental venous anomalies. Clin Neuroradiol 2014;24:135–43 doi:10.1007/s00062-013-0235-9 pmid:24240482

    CrossRefPubMed
23. 23.↵
    1. Jones BV,
    2. Linscott L,
    3. Koberlein G, et al

    . Increased prevalence of developmental venous anomalies in children with intracranial neoplasms. AJNR Am J Neuroradiol 2015;36:1782–85 doi:10.3174/ajnr.A4352 pmid:26021620

    Abstract/FREE Full Text
24. 24.↵
    1. Meng G,
    2. Bai C,
    3. Yu T, et al

    . The association between cerebral developmental venous anomaly and concomitant cavernous malformation: an observational study using magnetic resonance imaging. BMC Neurol 2014;14:50 doi:10.1186/1471-2377-14-50 pmid:24628866

    CrossRefPubMed
25. 25.↵
    1. Riant F,
    2. Bergametti F,
    3. Ayrignac X, et al

    . Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J 2010;277:1070–75 doi:10.1111/j.1742-4658.2009.07535.x pmid:20096038

    CrossRefPubMed
26. 26.↵
    1. Linscott LL,
    2. Leach JL,
    3. Jones BV, et al

    . Developmental venous anomalies of the brain in children – imaging spectrum and update. Pediatr Radiology 2016;46:394–406, quiz 391–93 doi:10.1007/s00247-015-3525-3 pmid:26795616

    CrossRefPubMed
27. 27.↵
    1. Treglia G,
    2. Muoio B,
    3. Trevisi G, et al

    . Diagnostic performance and prognostic value of PET/CT with different tracers for brain tumors: a systematic review of published meta-analyses. Int J Mol Sci 2019;20 doi:10.3390/ijms20194669b pmid:31547109

    CrossRefPubMed
28. 28.↵
    1. Patay Z,
    2. Orr BA,
    3. Shulkin BL, et al

    . Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria. J Inherit Metab Dis 2015;38:273–77 doi:10.1007/s10545-014-9782-8 pmid:25338511

    CrossRefPubMed